Why invest in Hofseth BioCare?
A strong ESG-profile, and patented processes coupled with world class R&D with diversified pipelines including research programs on asthma, COVID-19 and gastro
Ticker:
HBC
Last updated:
25.02.2021 16:09
Latest
8.76 NOK
Change
-0.16
Change (%)
-1.79
Share information
IR contact
News
Reports
Governance
LATEST REPORT
Q4 2020 Report
Download our latest report, or view all quarterly and yearly reports in the archives.
NEXT UP
Financial calendar
Annual Report 2020
19.03.2021
Annual General Meeting
23.04.2021
Investor presentation
Download our latest investor presentation in PDF-format for a even deeper insight into our current ongoing business and future potential.
Download presentation
Stock exchange notices
View all notices
Contact investor relations
